AzTrials
AzTrials

COVID-19SARS-CoV-2NCT05665205

Benefits of an Aerobic and Strength Rehabilitation Program With Post- SARS-CoV-2 Patients Moderate-severe

A study testing Aerobic plus strength group and Aerobic group in people with COVID-19, run by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The SARS-CoV-2 is a pulmonary pathology which is caused by SARS-COV2 and the main signs and symptoms are fever, dyspnea, cough, fatigue, muscular pain and more. Even if SARS-CoV-2 is an acute respiratory pathology we know that can cause some chronic conditions in the general status health of the patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
COVID-19
What is being tested?
Aerobic plus strength group and Aerobic group
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteSpain
Study dates
30 Jan 2023to 30 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients had been got covid in the last 2 years.
  • No fractures, or major injuries which could compromised the movements of the patient
  • No major pathologies which deteriorate the general health status

Who cannot join

  • Psychiatric (moderate to severe)
  • Acute infection
  • Fractures (moderate to severe)
  • Cognitive detrimental state

Trial locations and contacts

1 site in 1 country.

David Fernández, msc contact

696306962

david.fisioterapeuta14@gmail.com

Astrid Texeira Taborda, msc contact

astrid.teixeira@hgvillalba.es

Spain1 site
  • David Fernández

    Madrid, 28015

    David Fernández, Msc, 696306962, david.fisioterapeuta14@gmail.com

    Astrid Texeira Taborda, Msc

Other trials in Spain

About this study

Official title: Benefits of an Aerobic and Strength Rehabilitation Program With Post-SARS-CoV-2 Patients Moderate-severe

The SARS-CoV-2 is a pulmonary pathology which is caused by SARS-COV2 and the main signs and symptoms are fever, dyspnea, cough, fatigue, muscular pain and more. Even if SARS-CoV-2 is an acute respiratory pathology we know that can cause some chronic conditions in the general status health of the patients. Besides, it can have an important impact in the physique condition such as a detrimental of the aerobic capacity, lung capacity based on the severity of the patient.

On the other hand, World Health Organization (WHO) has a criteria to classify the severity of SARS-CoV-2;

Read more

Saturation de O2 <94%,

PaO2/FiO2: <300mm

Frecuencia respiratoria > 30p/m

abscess Lung > 50%

septic shock

Multiorganic failure

Based on the high survival but the important number of side effects of this pathology remaining the detrimental of the health and exercise condition. We justify our study based on an aerobic exercise program with a strength part to improve those conditions of the patients.

Read the detailed description

The investigators develop an aerobic exercise program for two treatment groups which one of them has a strength program as a supplement to verify if the aerobic exercise plus strength improve more than aerobic exercise alone the condition of COVID patients.

The protocol is based on 8 weeks of program with a baseline measurements and a follow ups after the 8º weeks, at 2, 4 and six months after finish the treatment to compare the effectiveness of both treatment and between them.

Conditions
COVID-19
Being tested
Aerobic plus strength group, Aerobic group
Keywords
Rehabilitation, COVID, Strenght exercise, Aerobic program
Medical subject headings
COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic plus strength groupOther

    A 8 week program of aerobic exercise plus strength exercise of upper and lower limbs in the hospital with a supervised trained physiotherapist

  • Aerobic groupOther

    This group has a 8 weeks program of only aerobic exercise in the hospital with a supervised trained physiotherapist.

Study groups in NCT05665205
Study groupRoleWhat they receive
Aerobic exercise plus strengthActive comparatorThe purpose is to verify if the aerobic exercise plus a strength program improves more than aerobic exercise alone in COVID patients.
Receives: Other: Aerobic plus strength group
Aerobic exercise aloneSham comparatorThe purpose is to verify if COVID patients can improve the status of their health only with an aerobic exercise program alone.
Receives: Other: Aerobic group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 6MWT

    The 6-minute walking test (6MWT) measured the cardiovascular endurance and the Functional Independence Measure assessed the global functional capacity

    Measured: 6 minutes

  2. sf 36

    The 36-Item Short Form Health Survey (SF-36) is a widely it. The measure meets high psychometric standards [20, 21]. The 36 items represent eight scales: Physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional and mental health. These eight scales form two higher order constructs: physical health (the first four scales) and mental health (the latter four scales). These constructs are represented by two summary measures: Physical Component Summary (PCS) measure and Mental Component Summary (MCS) measure. Scoring was completed as per standard instructions, using norm-based scoring algorithms. Lower scores on the MCS refect "frequent psychological distress, substantial social and role disability due to emotional problems; health in general rated 'poor'". Lower scores on the PCS refect "Substantial limitations in self-care, physical, social, and role activities; severe bodily pain; frequent tiredness; health rated 'poor'"

    Measured: 36 minutes

  3. Timed up and Go (TUG)

    Functional mobility was assessed through the timed up-and-go (TUG) test, five times sit-to-stand (FTSTS) test, functional reach and balance confidence. The TUG test measures the time taken by a participant to stand from a sitting position, walk 3 m, return and sit back down and is a measure of mobility. The FTSTS measures the time taken by a participant to switch from sitting-to-standing five times in a row and is a test of functional strength. Functional reach measures the distance a participant can reach forward with his or her arm outstretched while standing and is a test of balance. For each test, participants completed a practice run before the actual measurement

    Measured: 5-7 minutes

Secondary outcomes (5)
  1. BORG

    it is a scale that has been used to evaluate the degree of dyspnea (0=no dyspnea, 10=worse dyspnea)

    Measured: 10 seconds

  2. Ecography

    quadriceps muscle length will be measured

    Measured: 2-3 minutes

  3. Heart beat

    the heart beat will be measured before and during the treatment sessions

    Measured: 45 min

  4. Saturation

    Before the session and during the itself will be measured

    Measured: 45 min

  5. SARC-F questionnaire

    SARC-F includes five components: strength, assistance walking, rise from a chair, climb stairs, and falls. SARC-F items were selected to reflect health status changes associated with the consequences of sarcopenia. SARC-F scale scores range from 0 to 10 (i.e. 0-2 points for each component; 0 = best to 10 = worst) and were dichotomized to represent symptomatic (4+) vs. healthy (0-3) status

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2022
  2. Study start30 Jan 2023 (estimated)
  3. Primary completion30 Jan 2023 (estimated)
  4. Study completion30 Aug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05665205
Sponsor's protocol ID
COV_2022
Acronym
SARS-CoV-2
Status last verified
Dec 2022
First submitted
22 Dec 2022
Last updated
29 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: When the study will be completed and published, It will be available to share with more researches.

Publications

  • Bohannon RW, Crouch R. 1-Minute Sit-to-Stand Test: SYSTEMATIC REVIEW OF PROCEDURES, PERFORMANCE, AND CLINIMETRIC PROPERTIES. J Cardiopulm Rehabil Prev. 2019 Jan;39(1):2-8. doi: 10.1097/HCR.0000000000000336.

    PubMed 30489442
  • Vilagut G, Valderas JM, Ferrer M, Garin O, Lopez-Garcia E, Alonso J. [Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components]. Med Clin (Barc). 2008 May 24;130(19):726-35. doi: 10.1157/13121076. Spanish.

    PubMed 18570798

Questions about this trial

What is this clinical trial studying?

A study testing Aerobic plus strength group and Aerobic group in people with COVID-19, run by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact David Fernández, msc (696306962, david.fisioterapeuta14@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

6MWT (time frame: 6 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05665205, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in